These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17457304

  • 1. Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.
    Cho YM, Takahashi S, Asamoto M, Suzuki S, Tang M, Shirai T.
    Prostate Cancer Prostatic Dis; 2007; 10(4):378-83. PubMed ID: 17457304
    [Abstract] [Full Text] [Related]

  • 2. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S, Kuliyev E, Steakley M, Greenberg N, Steiner MS.
    Cancer Res; 2000 Aug 01; 60(15):4093-7. PubMed ID: 10945615
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor.
    Zeng Y, Yokohira M, Saoo K, Takeuchi H, Chen Y, Yamakawa K, Matsuda Y, Kakehi Y, Imaida K.
    Carcinogenesis; 2005 Jun 01; 26(6):1109-16. PubMed ID: 15731164
    [Abstract] [Full Text] [Related]

  • 4. Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment.
    Cho YM, Takahashi S, Asamoto M, Suzuki S, Inaguma S, Hokaiwado N, Shirai T.
    Cancer Sci; 2003 Feb 01; 94(2):153-7. PubMed ID: 12708490
    [Abstract] [Full Text] [Related]

  • 5. Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats.
    Imada S, Akaza H, Ami Y, Koiso K, Ideyama Y, Takenaka T.
    Eur Urol; 1997 Feb 01; 31(3):360-4. PubMed ID: 9129932
    [Abstract] [Full Text] [Related]

  • 6. Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat.
    Wang Z, Luque RM, Kineman RD, Ray VH, Christov KT, Lantvit DD, Shirai T, Hedayat S, Unterman TG, Bosland MC, Prins GS, Swanson SM.
    Endocrinology; 2008 Mar 01; 149(3):1366-76. PubMed ID: 18079205
    [Abstract] [Full Text] [Related]

  • 7. Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia.
    Alberts SR, Blute ML.
    Urology; 2001 Apr 01; 57(4 Suppl 1):188-90. PubMed ID: 11295624
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preventive Effects of Fermented Brown Rice and Rice Bran against Prostate Carcinogenesis in TRAP Rats.
    Kuno T, Nagano A, Mori Y, Kato H, Nagayasu Y, Naiki-Ito A, Suzuki S, Mori H, Takahashi S.
    Nutrients; 2016 Jul 11; 8(7):. PubMed ID: 27409632
    [Abstract] [Full Text] [Related]

  • 13. Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.
    Shibata Y, Ono Y, Kashiwagi B, Suzuki K, Fukabori Y, Honma S, Yamanaka H.
    Urology; 2003 Nov 11; 62(5):942-6. PubMed ID: 14624931
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
    Monti S, Sciarra F, Adamo MV, Toscano V, Trotta MC, Martini C, Lanzara S, Silverio FD.
    J Androl; 1997 Nov 11; 18(5):488-94. PubMed ID: 9349746
    [Abstract] [Full Text] [Related]

  • 16. Combined treatment with the 5 alpha-reductase inhibitor PNU 157706 and the antiandrogen flutamide on the Dunning R3327 prostatic carcinoma in rats.
    Zaccheo T, Giudici D, di Salle E.
    Endocr Relat Cancer; 1999 Sep 11; 6(3):429-35. PubMed ID: 10516856
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W, Kearbey JD, Nair VA, Chung K, Parlow AF, Miller DD, Dalton JT.
    Endocrinology; 2004 Dec 11; 145(12):5420-8. PubMed ID: 15308613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.